Glossary
Nancy F Scheraga
FDA Investigator Details
Nancy F Scheraga
Visit Investigator ProfileInvestigation Details
Last Issued Date
July 13, 2018
Conversion Rate
0
% Conversion
No. of 483’s Issued
4
Warning Letters Issued
1
Countries Inspected
USA
FDA Investigators having one site common
Detailed Analysis
Approach:
Inspector Scheraga highly emphasizes on complete and accurate testing and validation procedures technology-wise. She looks transparently and in-depth into the pharmaceutical production and quality control processes and focuses on preventing potential issues before they become significant problems.
Profile:
FDA Inspector Nancy F Scheraga is particularly proficient at and focusing on stability data and expiry dates of drug products, conformance testing before drug release, and sterilization process validation. She demands high standards of accuracy in testing and validation processes and is meticulous in examining compliance with FDA regulations.
Top Process Types:
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now
